Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1994 1
1995 1
1997 1
2004 2
2007 2
2008 4
2009 3
2010 2
2011 3
2012 1
2013 7
2014 2
2015 9
2016 5
2017 13
2018 15
2019 9
2020 26
2021 35
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Results by year
Filters applied: . Clear all
Page 1
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
Fox E, Lovett-Racke AE, Gormley M, Liu Y, Petracca M, Cocozza S, Shubin R, Wray S, Weiss MS, Bosco JA, Power SA, Mok K, Inglese M. Fox E, et al. Among authors: petracca m. Mult Scler. 2021 Mar;27(3):420-429. doi: 10.1177/1352458520918375. Epub 2020 Apr 30. Mult Scler. 2021. PMID: 32351164 Free PMC article. Clinical Trial.
Sodium MRI of multiple sclerosis.
Petracca M, Fleysher L, Oesingmann N, Inglese M. Petracca M, et al. NMR Biomed. 2016 Feb;29(2):153-61. doi: 10.1002/nbm.3289. Epub 2015 Apr 6. NMR Biomed. 2016. PMID: 25851455 Free PMC article. Review.
MRI in multiple sclerosis: clinical and research update.
Inglese M, Petracca M. Inglese M, et al. Among authors: petracca m. Curr Opin Neurol. 2018 Jun;31(3):249-255. doi: 10.1097/WCO.0000000000000559. Curr Opin Neurol. 2018. PMID: 29561520 Review.
Clinical differences between botulinum neurotoxin type A and B.
Bentivoglio AR, Del Grande A, Petracca M, Ialongo T, Ricciardi L. Bentivoglio AR, et al. Among authors: petracca m. Toxicon. 2015 Dec 1;107(Pt A):77-84. doi: 10.1016/j.toxicon.2015.08.001. Epub 2015 Aug 7. Toxicon. 2015. PMID: 26260691 Review.
127 results